|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.65 CNY | 0.00% |
|
+3.52% | +0.17% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 5.1% | 5.38% | 13.54x | 2.54x | 0.55x | 4.41x | 7.28x | 2.96B | |
| -.--% | -.--% | 17.56x | 1.55x | 0.73x | 11.51x | 12.36x | 15.2B | |
| -.--% | 0.96% | 21.47x | 2.62x | 1.07x | 16.5x | 16.87x | 7.15B | |
| 2.34% | 2.65% | 15.93x | 1.67x | 0.71x | 7.4x | 9.33x | 5.9B | |
| 3.37% | 3.71% | 12.72x | 1.91x | 0.81x | 5.82x | 7.62x | 3.6B | |
| 4.17% | 4.58% | 15.5x | 7.01x | 0.94x | 7.02x | 9.75x | 3.23B | |
| 5.73% | 6.45% | 14.23x | 4.3x | 1.22x | 7.35x | 14.25x | 3.18B | |
| 1.77% | 2.14% | 23.22x | 4.06x | 0.66x | 8.53x | 13.97x | 1.71B | |
| 0.01% | -.--% | -81.46x | 2.68x | 0.43x | 16.12x | 97.44x | 1.42B | |
| 5.57% | 6.2% | 12.98x | 2.35x | 0.87x | 7.14x | 14.08x | 964M | |
| 4.68% | 5.28% | 10.83x | 0.77x | 0.25x | 2.41x | 4.98x | 857M | |
| 1.34% | 1.94% | 27.33x | 7.36x | 0.97x | 13.41x | 21.26x | 807M | |
| 0.36% | 0.37% | 14.42x | 1.95x | 0.69x | 8.45x | 13.64x | 710M | |
| Average | 2.65% | 3.05% | 9.10x | 3.13x | 0.76x | 8.93x | 18.68x | 3.67B | |
| Weighted average by Cap. | 1.81% | 2.16% | 14.14x | 2.60x | 0.81x | 10.06x | 14.59x |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
